RT Journal Article
SR Electronic
T1 Setting up a homecare service for zoledronic acid treatment of osteoporosis
JF European Journal of Hospital Pharmacy
JO Eur J Hosp Pharm
FD British Medical Journal Publishing Group
SP 364
OP 365
DO 10.1136/ejhpharm-2015-000742
VO 23
IS 6
A1 See Mun Wong
A1 Sarah Pacey
A1 Opinder Sahota
YR 2016
UL http://ejhp.bmj.com/content/23/6/364.abstract
AB Increasingly, patients are able to receive parenteral medicines at home rather than in the hospital setting. We describe our approach to setting up a new intravenous zoledronic acid homecare service for patients with osteoporosis. Initial evaluation of service feasibility demonstrated a marginal cost saving of approximately 6%, when the drug is administered via homecare compared with hospital day-case unit. Rigorous risk assessment was conducted prior to service initiation. Implementation strategies are outlined. Surveys confirmed that the majority of patients were highly satisfied with the home infusion service.